Support for JAK inhibitors as ‘drug of choice’ for patients with PsA and significant joint disease medwireNews, 18 Oct 2022 18-10-2022 | Rheumatology | News | Article medwireNews: Janus kinase (JAK) inhibitors show promise for the treatment of moderate…